NCT04858126 is a NA clinical trial of ECOM cardiac output in Hemodynamic Monitoring, sponsored by ECOM Medical, Inc..

Who is sponsoring NCT04858126?

NCT04858126 is sponsored by ECOM Medical, Inc..

What drugs are being tested in NCT04858126?

Interventions in NCT04858126: ECOM cardiac output.

What condition does NCT04858126 study?

NCT04858126 studies Hemodynamic Monitoring.

Is NCT04858126 still recruiting?

NCT04858126 is currently completed. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT04858126

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accuracy of ECOM Plus Versus Pulmonary Artery Catheter

Completed NA Last updated 20 February 2024

What this trial tests

NA trial testing ECOM cardiac output in Hemodynamic Monitoring in 110 participants. Completed in 11 September 2023.

Timeline

1 January 2021

Primary endpoint
11 September 2023

11 September 2023

Quick facts

Lead sponsor	ECOM Medical, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	110
Start date	1 January 2021
Primary completion	11 September 2023
Estimated completion	11 September 2023
Sites	1 location across United States

Drugs / interventions tested

ECOM cardiac output

Conditions studied

Hemodynamic Monitoring — all drugs for Hemodynamic Monitoring →

Sponsor

ECOM Medical, Inc.

Who can join

18 and older, any sex, with Hemodynamic Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This Study will compare the accuracy of the ECOM Plus Endotracheal Cardiac Output Monitor (ECOM) without the use of the arterial pressure waveform from the arterial line to 1) the current clinical standard of cardiac output measured by intermittent room temperature bolus thermodilution using a PAC, 2) the current ECOM System with the use of the arterial blood pressure waveform from a radial arterial line and 3) the Flo-Trac® System.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemodynamic Monitoring

Currently open trials in the same condition.

NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
NCT07062744 — The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock · NA · recruiting
NCT06918301 — Comparison of Cardiac Index and Stroke-volume-index Measured by Pulmonary Artery Catheter, FloTrac® and Argos® in Cardia · recruiting
NCT07270341 — Evaluation of Cerebral Oxygenation During Orthopedic Surgeries Performed in the Beach Chair Position Under General Anest · recruiting
NCT04281771 — Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04858126 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ECOM Medical, Inc.
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04858126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing